Correlation Between Monopar Therapeutics and Bio Path

Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Monopar Therapeutics and Bio Path Holdings, you can compare the effects of market volatilities on Monopar Therapeutics and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Bio Path.

Diversification Opportunities for Monopar Therapeutics and Bio Path

-0.42

Correlation Coefficient

Monopar Therapeutics  Bio Path

Very good diversification

The 3 months correlation between Monopar and Bio is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Bio Path go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and Bio Path

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 11.56 times more return on investment than Bio Path. However, Monopar Therapeutics is 11.56 times more volatile than Bio Path Holdings. It trades about 0.14 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.03 per unit of risk. If you would invest  237.00  in Monopar Therapeutics on September 3, 2024 and sell it today you would earn a total of  2,016  from holding Monopar Therapeutics or generate 850.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Monopar Therapeutics  vs.  Bio Path Holdings

Monopar Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Bio Path Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Monopar Therapeutics and Bio Path

The main advantage of trading using opposite Monopar Therapeutics and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.

The idea behind Monopar Therapeutics and Bio Path Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.